|
IsoTherapeutics Group (ITG) is a radiopharmaceutical development company that launched R&D services in 2005 to aid customers and collaborators in the development of pharmaceuticals. The company has earned a solid reputation in radiochemistry, radiolabeling, and process/product development. ITG has recently enhanced its capabilities to help customers with cGMP radiopharmaceutical manufacturing for clinical trials. This helps ensure seamless development of products from research to clinical trial-stage manufacturing.
IsoTherapeutics offers host of services to the
pharmaceutical and life-science industries. The
company specializes in R&D of
radiopharmaceuticals that are targeted at
detecting and treating debilitating
diseases. The range of services include helping
customers/partners with early stage research
from proof of concept for a new chemistry or
drug molecule through making of the drug in a
cGMP facility for preclinical studies.
These services include:
- Radiopharmaceuticals
- Chelation
- Conjugation
- Isotope Selection
- Radiolabeling
- Synthetic Chemistry
- Small Animal Studies
- Target processing/Radiochemical processing
- Kit Development and manufacturing
- GLP and cGMP Services
The company also
plays an advisory role based on its 100+ years
of collective experience. The
company works with customers in a variety ways
and engages with customers every step of the way
with the final goal being reduction of costs and
shortening of the time to clinical trial.
View Our Brochure 
|
